LON:IDH Immunodiagnostic Systems (IDH) Share Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free IDH Stock Alerts GBX 378 0.00 (0.00%) (As of 07/12/2021) Add Compare Share Share Today's Range 378▼ 37850-Day Range 378▼ 37852-Week Range 180▼ 380VolumeN/AAverage Volume14,539 shsMarket Capitalization£108.80 millionP/E Ratio290.77Dividend Yield0.01%Price TargetN/A Stock AnalysisStock Analysis Get Immunodiagnostic Systems alerts: Email Address Ad Stansberry ResearchUrgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.Find out for free here. About Immunodiagnostic Systems Stock (LON:IDH)Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.Read More IDH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IDH Stock News HeadlinesMarch 25, 2024 | markets.businessinsider.comEQS-News: DATAGROUP Acquires ISC Innovative Systems Consulting AGMarch 21, 2024 | msn.com2025 Volkswagen ID.7 First Drive Review: Okay, I Get It NowMay 2, 2024 | Stansberry Research (Ad)$5,000 Gold?Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now).March 21, 2024 | msn.comVolkswagen ID.4 Makes Debut In India, Set To Hit Roads SoonAugust 8, 2023 | msn.comFarewell, Fake IDs: Age Verification Gets an UpgradeJune 26, 2023 | msn.comRevenues and profits rise at Immunodiagnostic Systems in year after £110m takeoverJune 20, 2023 | lse.co.ukIDH.L Regulatory NewsJune 9, 2023 | finanznachrichten.deImmunohistochemistry (IHC) Market worth $4.7 billion | MarketsandMarketsMay 2, 2024 | Stansberry Research (Ad)$5,000 Gold?Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now).May 13, 2023 | forbes.com10 Best Leave Management Systems In 2023April 8, 2023 | marketwatch.com2023-2029 Immunodiagnostic Equipment Market Share and Growth Opportunities | Report by Industry ExpertsFebruary 23, 2023 | forbes.comEpic SystemsFebruary 18, 2023 | marketwatch.comVeterinary Immunodiagnostic Device Market Analysis Report 2023 Along with Statistics Figures, till 2029See More Headlines Receive IDH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/20/2018Today5/02/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Appliances & Equipment Sub-IndustryN/A Current SymbolLON:IDH CUSIPN/A CIKN/A Webwww.idsplc.com Phone+44-191-5190660FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio290.77 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio6.84 Current Ratio5.40 Quick Ratio3.87 Sales & Book Value Annual Sales£34.25 million Price / Sales3.18 Cash FlowGBX 84 per share Price / Cash Flow4.50 Book ValueGBX 187.60 per share Price / Book2.01Miscellaneous Outstanding Shares28,784,000Free FloatN/AMarket Cap£108.80 million OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jaap Stuut (Age 51)CEO & Director Comp: $284kMr. Paul J. MartinGroup Fin. Director, Company Sec. & DirectorMr. Sander Perret GentilHead of Marketing & CommunicationsNicola MittonGroup HR DirectorMr. Ed Coombes (Age 50)Head Of Bus. Devel. - Instrumentation Dr. Rudolf Schemer Ph.D. (Age 60)CEO of GeschTMaftsfuhrer at IDS GmbH Frankfurt & Country Mang. of Germany Region More ExecutivesKey CompetitorsIntelligent Ultrasound Group plc (MED.L)LON:MEDKoothLON:KOOVerseonLON:VSNTiziana Life SciencesLON:TILSFutura MedicalLON:FUMView All Competitors IDH Stock Analysis - Frequently Asked Questions How have IDH shares performed in 2024? Immunodiagnostic Systems' stock was trading at GBX 378 on January 1st, 2024. Since then, IDH shares have increased by 0.0% and is now trading at GBX 378. View the best growth stocks for 2024 here. How were Immunodiagnostic Systems' earnings last quarter? Immunodiagnostic Systems Holdings PLC (LON:IDH) issued its earnings results on Wednesday, June, 20th. The company reported $5.70 earnings per share for the quarter, beating analysts' consensus estimates of $2.60 by $3.10. Is Immunodiagnostic Systems a good dividend stock? Immunodiagnostic Systems (LON:IDH) pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 0.50%. The dividend payout ratio is 1.46%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for IDH. What other stocks do shareholders of Immunodiagnostic Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP), Telford Homes (TEF), WisdomTree U.S. Multifactor Fund (USMF), American Tower (AMT) and Advanced Medical Solutions Group (AMS). How do I buy shares of Immunodiagnostic Systems? Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:IDH) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYour bank is lying to you.MyBankTrackerTrump just won 2024Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingA once-in-a-century investment opportunityStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunodiagnostic Systems Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.